Latest news with #DOCU
Yahoo
28-06-2025
- Business
- Yahoo
Jim Cramer on DocuSign Stock: 'It's Time to Sell'
DocuSign, Inc. (NASDAQ:DOCU) is one of the 11 stocks Jim Cramer put under the microscope recently. Answering a caller's query about the company during the lightning round, Cramer stated: 'You know, I thought the last quarter was good, and nobody liked it. I swear to God, I thought all the different innovations were good. People thought the revenues were too weak. I'm going to go with the flow and tell you it's time to sell.' A software engineer in front of a computer screen, typing code to build the company's electronic signature software. DocuSign (NASDAQ:DOCU) provides an AI-driven agreement management platform that includes electronic signatures, automated contract workflows, document generation, and identity verification tools. For the fiscal year ending January 31, 2026, the company expects total revenue to be between $3.151 billion and $3.163 billion. Subscription revenue is projected to range from $3.083 billion to $3.095 billion. DocuSign (NASDAQ:DOCU) anticipates billings between $3.285 billion and $3.339 billion. Furthermore, the company's non-GAAP operating margin is expected to be between 27.8% and 28.8%. While we acknowledge the potential of DOCU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Globe and Mail
24-06-2025
- Business
- Globe and Mail
Better Cloud Stock: Docusign vs. Confluent
Docusign (NASDAQ: DOCU) and Confluent (NASDAQ: CFLT) both help companies streamline their businesses with their cloud-based services. Docusign is the world's largest provider of e-signature services, while Confluent's platform processes real-time data as it flows between different applications across an organization. But over the past 12 months, Docusign's stock price rose 44% as Confluent's stock slumped 13%. Let's see why the e-signature services leader outperformed the "data in motion" company by such a wide margin -- and if it will remain the better investment over the next few years. The differences between Docusign and Confluent Docusign serves over 1.4 million customers in 180 countries, and it's been used in more than a billion transactions. It generates most of its revenue from subscriptions to its e-signature platform, its contract lifecycle management (CLM) tools, and other cloud-based services. Confluent served 6,140 customers in its latest quarter. Its namesake platform runs on Apache Kafka, an open-source platform for streaming data, but it adds additional analytics tools to differentiate itself from other "Kafka-as-a-service" providers. It generates its revenue from a mix of subscriptions and more flexible consumption-based fees. Which company is growing faster? Docusign's growth is driven by the growing usage of digital documents and e-signatures as they replace their pen-and-paper counterparts. Confluent's growth is fueled by a need to evaluate data as it streams across the silos of a large organization. That real-time analysis gets everyone on the same page to make faster decisions. From fiscal 2021 to fiscal 2025 (which ended this January), Docusign's revenue grew at a CAGR of 20% as its adjusted gross margin rose from 79% to 82%. It also turned profitable on a generally accepted accounting principles (GAAP) basis over the past two fiscal years as it downsized its workforce and streamlined its spending. But from fiscal 2025 to fiscal 2028, analysts expect Docusign's revenue to grow at a slower CAGR of 8% as its core market matures, it laps some earlier-than-expected contract renewals from fiscal 2024, cautiously expands its new AI-driven Intelligent Agreement Management (IAM) platform, and deals with tougher competitive and macro headwinds. Analysts expect its GAAP EPS to decline in fiscal 2026 as it expands its lower-margin IAM platform while lapping some big buybacks and one-time tax benefits. But over the following two years, they expect its EPS to grow at a CAGR of 41% as it scales up its IAM platform and streamlines its spending. From 2020 to 2024, Confluent's revenue rose at a CAGR of 42% as its adjusted gross margin expanded from 70% to 79%. That growth was driven by the accelerating adoption of real-time data streaming services (especially among larger enterprise customers), the expansion of its higher-margin cloud-based ecosystem with more analytics tools, and its new overseas customers. But it's still never been profitable on a GAAP basis. From 2024 to 2027, analysts expect its revenue to grow at a CAGR of 19% as it gradually narrows its net losses. Its biggest potential catalysts include the growth of its cloud platform, fresh tailwinds from the booming AI market, and the expansion of its enterprise and overseas businesses. Which stock is a better value right now? Docusign's stock trades at 61 times forward earnings and 5 times this year's sales. Confluent can't be valued by its profits, but it trades at 7 times this year's sales. However, Docusign's insiders sold nearly 2.1 million shares over the past 12 months while only buying around 1,300 shares. Confluent's insiders bought 17.2 million shares and sold 17.6 million shares during the same period. That warmer insider sentiment suggests that Confluent might have a bit more upside potential than Docusign. The better buy: Confluent Docusign's stock rose over the past year as the bulls cheered the growth potential of its IAM platform in the AI market, but it's still being valued as a growth stock as its core business matures. Confluent should continue growing at a faster rate as its cloud platform expands, and its stock seems more reasonably valued relative to its growth potential. I wouldn't rush to buy either of these cloud-oriented stocks right now. But if I had to choose one over the other, I'd probably avoid Docusign and bet on a stronger recovery for Confluent -- which stands to process a lot more streaming data as the cloud and AI markets expand. Should you invest $1,000 in Docusign right now? Before you buy stock in Docusign, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Docusign wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025
Yahoo
24-06-2025
- Business
- Yahoo
Better Cloud Stock: Docusign vs. Confluent
Docusign's business is maturing, but its profits are rising. Confluent is growing at a faster rate, but it isn't profitable yet. Insiders are fleeing one stock a lot faster than the other. 10 stocks we like better than Docusign › Docusign (NASDAQ: DOCU) and Confluent (NASDAQ: CFLT) both help companies streamline their businesses with their cloud-based services. Docusign is the world's largest provider of e-signature services, while Confluent's platform processes real-time data as it flows between different applications across an organization. But over the past 12 months, Docusign's stock price rose 44% as Confluent's stock slumped 13%. Let's see why the e-signature services leader outperformed the "data in motion" company by such a wide margin -- and if it will remain the better investment over the next few years. Docusign serves over 1.4 million customers in 180 countries, and it's been used in more than a billion transactions. It generates most of its revenue from subscriptions to its e-signature platform, its contract lifecycle management (CLM) tools, and other cloud-based services. Confluent served 6,140 customers in its latest quarter. Its namesake platform runs on Apache Kafka, an open-source platform for streaming data, but it adds additional analytics tools to differentiate itself from other "Kafka-as-a-service" providers. It generates its revenue from a mix of subscriptions and more flexible consumption-based fees. Docusign's growth is driven by the growing usage of digital documents and e-signatures as they replace their pen-and-paper counterparts. Confluent's growth is fueled by a need to evaluate data as it streams across the silos of a large organization. That real-time analysis gets everyone on the same page to make faster decisions. From fiscal 2021 to fiscal 2025 (which ended this January), Docusign's revenue grew at a CAGR of 20% as its adjusted gross margin rose from 79% to 82%. It also turned profitable on a generally accepted accounting principles (GAAP) basis over the past two fiscal years as it downsized its workforce and streamlined its spending. But from fiscal 2025 to fiscal 2028, analysts expect Docusign's revenue to grow at a slower CAGR of 8% as its core market matures, it laps some earlier-than-expected contract renewals from fiscal 2024, cautiously expands its new AI-driven Intelligent Agreement Management (IAM) platform, and deals with tougher competitive and macro headwinds. Analysts expect its GAAP EPS to decline in fiscal 2026 as it expands its lower-margin IAM platform while lapping some big buybacks and one-time tax benefits. But over the following two years, they expect its EPS to grow at a CAGR of 41% as it scales up its IAM platform and streamlines its spending. From 2020 to 2024, Confluent's revenue rose at a CAGR of 42% as its adjusted gross margin expanded from 70% to 79%. That growth was driven by the accelerating adoption of real-time data streaming services (especially among larger enterprise customers), the expansion of its higher-margin cloud-based ecosystem with more analytics tools, and its new overseas customers. But it's still never been profitable on a GAAP basis. From 2024 to 2027, analysts expect its revenue to grow at a CAGR of 19% as it gradually narrows its net losses. Its biggest potential catalysts include the growth of its cloud platform, fresh tailwinds from the booming AI market, and the expansion of its enterprise and overseas businesses. Docusign's stock trades at 61 times forward earnings and 5 times this year's sales. Confluent can't be valued by its profits, but it trades at 7 times this year's sales. However, Docusign's insiders sold nearly 2.1 million shares over the past 12 months while only buying around 1,300 shares. Confluent's insiders bought 17.2 million shares and sold 17.6 million shares during the same period. That warmer insider sentiment suggests that Confluent might have a bit more upside potential than Docusign. Docusign's stock rose over the past year as the bulls cheered the growth potential of its IAM platform in the AI market, but it's still being valued as a growth stock as its core business matures. Confluent should continue growing at a faster rate as its cloud platform expands, and its stock seems more reasonably valued relative to its growth potential. I wouldn't rush to buy either of these cloud-oriented stocks right now. But if I had to choose one over the other, I'd probably avoid Docusign and bet on a stronger recovery for Confluent -- which stands to process a lot more streaming data as the cloud and AI markets expand. Before you buy stock in Docusign, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Docusign wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Docusign. The Motley Fool recommends Confluent. The Motley Fool has a disclosure policy. Better Cloud Stock: Docusign vs. Confluent was originally published by The Motley Fool
Yahoo
15-06-2025
- Business
- Yahoo
1 Magnificent Growth Stock Down 75% to Buy Hand Over Fist in June
Docusign stock was a pandemic darling, but the stock couldn't sustain its momentum once social distancing efforts ended. Docusign stock is down 75% from its 2021 peak, but the company continues to deliver steady revenue growth and its profits are soaring. The stock now trades at an attractive valuation relative to its history, and artificial intelligence (AI) could fuel its next move higher. 10 stocks we like better than Docusign › Docusign (NASDAQ: DOCU) stock soared to a peak of $310 in 2021 on the back of an incredible spike in demand for the company's suite of digital document tools, which helped businesses keep their operations running smoothly in the face of the pandemic's lockdowns and social distancing restrictions. Since that pandemic tailwind subsided, the stock has slumped by 75% from that peak, but the business itself is still generating steady revenue growth, and its profits are currently soaring. Plus, Docusign is experiencing strong demand for its new Intelligent Agreement Management (IAM) platform, which is powered by artificial intelligence (AI). On June 6, Docusign reported results for its fiscal 2026 first quarter (which ended April 30), and management increased its full-year revenue guidance, which signals clear momentum across the business. Here's why investors might want to buy the stock now. Docusign transformed its product portfolio over the past year. It still helps businesses create, negotiate, and close contracts, but AI is now at the center of that mission. The IAM platform is designed to solve the "agreement trap" more effectively. According to a study by Deloitte, the inefficiencies caused by poor contract management processes result in $2 trillion in lost economic value every year. That represents a massive opportunity for Docusign. IAM features a growing list of revolutionary products. Navigator, for example, is a digital repository where businesses can store their agreements. It uses AI to extract critical details from each document so they are discoverable via its search function, which saves employees from spending valuable time digging through contracts manually. Then there is AI-Assisted Review, which can help employees rapidly identify problematic clauses or even opportunities within each agreement. Businesses can also set pre-approved standards so the tool knows exactly what to look for, which reduces the time it takes to reach a final deal. Maestro ties the IAM platform together with a series of no-code tools that allow businesses to automate agreement workflows. They can drag-and-drop features like webforms, ID verification, and eSignature into each contract, which saves significant amounts of time and money compared to manual processes, especially when creating agreements at scale. At the end of its first quarter of fiscal 2026, Docusign had 1.7 million paying enterprise customers and more than 1 billion individual users. The company launched the IAM platform in April 2024, and it already has 10,000 paying enterprise customers who have used it to process tens of millions of agreements so far. During the quarter, IAM sales in international markets soared by 50% compared to fiscal 2025 Q4, which highlights the platform's serious momentum. Docusign generated $763.7 million in total revenue during fiscal Q1. That was an 8% increase from the year-ago period, and comfortably above the $749 million that had been the high end of management's guidance range. In fact, the strong result prompted the company to revise its revenue forecast for fiscal 2026 upward by $22 million to $3.163 billion at the high end of the range. In my opinion, Docusign could be growing its revenue more quickly, but it's carefully managing its costs to improve its bottom line rather than investing more heavily in customer acquisition. The company's total operating expenses only increased by 1.6% year over year during the first quarter, which was a much slower rate than its revenue increased. As a result, its net income surged by 113.5% to $72.1 million on a GAAP (generally accepted accounting principles) basis. Docusign also achieved a solid result in the bottom line on a non-GAAP basis, which excludes one-off and non-cash expenses like stock-based compensation. Non-GAAP net income came in at $190.8 million, which was an increase of 10% from the year-ago period. Non-GAAP results can be particularly useful for investors to consider when a company incurs a large one-off benefit or expense. For example, during Docusign's fiscal 2025 second quarter, it reported a large one-off tax benefit worth $816 million which massively skewed its net income, so its GAAP earnings weren't a true reflection of the performance of its actual business. When Docusign stock peaked in 2021, its price-to-sales (P/S) ratio soared to an unsustainable level of around 40. The 75% decline in its stock since then, combined with the company's steady revenue growth, has pushed its P/S ratio down to a more reasonable 5.4. In fact, that's a 56% discount to its average P/S ratio of 12.5 since the stock went public in 2018. Docusign also trades at a price-to-earnings (P/E) ratio of just 14.6, which makes it far cheaper than the S&P 500 index, which is trading at a P/E ratio of 23.3. However, that is based on Docusign's trailing 12-month GAAP earnings per share (EPS) which, as I mentioned earlier, was skewed by a one-off tax benefit from the second quarter of fiscal 2025. Therefore, the P/S ratio might be a better way to value the stock right now, but no matter which way you slice it, Docusign's valuation appears attractive. The picture looks even better when you factor in the company's addressable market, which could be worth $50 billion according to an estimate issued by management last year. Based on its current revenue, it has barely scratched the surface of that opportunity. In summary, Docusign stock can offer investors unique exposure to the AI revolution, and its combination of steady revenue growth and soaring profits could make it a great addition to any diversified portfolio at the current price. Before you buy stock in Docusign, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Docusign wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $655,255!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $888,780!* Now, it's worth noting Stock Advisor's total average return is 999% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Docusign. The Motley Fool has a disclosure policy. 1 Magnificent Growth Stock Down 75% to Buy Hand Over Fist in June was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
13-06-2025
- Business
- Yahoo
DOCU Shares Fall 18.2% Despite Q1 Earnings & Revenue Beat
DocuSign, Inc. DOCU reported impressive first-quarter fiscal 2026 results, wherein earnings per share (EPS) and revenues surpassed the Zacks Consensus Estimate. However, the better-than-expected results failed to impress the investors, as the stock has lost 18.2% since the company released results on June 5. Image Source: Zacks Investment Research DOCU's EPS (excluding 56 cents from non-recurring items) was 90 cents, which surpassed the Zacks Consensus Estimate by 11.1% and increased 9.8% from the year-ago quarter. Total revenues of $763.7 million beat the consensus mark by 2.2% and rose 7.6% from the first quarter of fiscal 2025. The company's shares have rallied 49.6% in the past year compared with the industry's 37.3% rise and the Zacks S&P 500's 10.8% growth. Image Source: Zacks Investment Research Subscription revenues totaled $746.2 million, increasing 8% year over year. The figure beat our estimate of $730.4 million. Professional services and other revenues of $17.5 million fell 4% from the year-ago quarter, beating our expectation of $17 million. Billings amounted to $739.6 million, up 4% from the year-ago quarter. The figure failed to meet our anticipation of $748.7 million. The non-GAAP gross margin was 82.3%, beating our estimate of 81.4%. The non-GAAP gross profit of $628.7 million grew 8% year over year and outpaced our expectation of $608.4 million. The non-GAAP operating margin was 29.5%, increasing 100 basis points from the year-ago quarter. It beat our estimate of 27.6%. DocuSign exited the first quarter of fiscal 2026 with cash and cash equivalents of $657.4 million compared with $817.4 million at the end of the first quarter of fiscal 2025. Net cash generated by operating activities was $251.4 million for the reported quarter. Free cash flow generated was $227.8 million. For the second quarter of fiscal 2026, the company expects revenues between $777 million and $781 million. The mid-point of the guided range ($779 million) is above the Zacks Consensus Estimate of $777.7 million. DOCU anticipates subscription revenues in the range of $760-$764 million and billing revenues between $757 million and $767 million. The non-GAAP gross margin and the non-GAAP operating margin are expected to be 80.5-81.5% and 26.5-27.5%, respectively. For fiscal 2026, the company expects revenues between $3.15 billion and $3.16 billion. The Zacks Consensus Estimate for the same is $3.15 billion. DOCU anticipates subscription revenues between $3.08 billion and $3.09 billion and billings between $3.29 billion and $3.34 billion. The non-GAAP gross margin and the non-GAAP operating margin are expected to be 80.7-81.7% and 27.8-28.8%, respectively. Currently, DocuSign carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Fiserv, Inc. FI reported mixed first-quarter 2025 results. The company's earnings beat the Zacks Consensus Estimate, while revenues missed the mark. FI's adjusted earnings per share of $2.14 beat the consensus mark by 2.9% and gained 13.8% year over year. Adjusted revenues of $4.8 billion lagged the consensus estimate by 1.6% but rose 5.5% on a year-over-year basis. (See the Zacks Earnings Calendar to stay ahead of market-making news.) The Interpublic Group of Companies, Inc. IPG reported mixed first-quarter 2025 results. The company's earnings topped the Zacks Consensus Estimate, while revenues missed the mark. IPG's adjusted earnings of 33 cents per share surpassed the Zacks Consensus Estimate by 10% but decreased 8.3% from the year-ago quarter. Revenues before billable expenses (net revenues) of $2 billion missed the consensus estimate by a slight margin and declined 20% year over year. Total revenues of $2.3 billion decreased 7.2% year over year but beat the Zacks Consensus Estimate of $2 billion. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Interpublic Group of Companies, Inc. (The) (IPG) : Free Stock Analysis Report Fiserv, Inc. (FI) : Free Stock Analysis Report Docusign Inc. (DOCU) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
